Insmed (INSM) PT Raised to $237 at Barclays
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $98.61 +2.93%
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Barclays analyst Eliana Merle raised the price target on Insmed (NASDAQ: INSM) to $237.00 (from $231.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $160 at Evercore ISI
- Volkswagen AG (VOW:GR) (VWAGY) PT Lowered to EUR120 at Barclays
- Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
